Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insomnia01:27

Insomnia

567
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
567
Management of Insomnia01:19

Management of Insomnia

761
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
761
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

515
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
515
Nightmares and Night Terrors01:18

Nightmares and Night Terrors

718
Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares...
718
Insufficient Sleep and Sleep Deprivation01:13

Insufficient Sleep and Sleep Deprivation

1.2K
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
1.2K
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

782
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
782

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Developmental outcome of electroencephalographic findings in SYNGAP1 encephalopathy.

Frontiers in cell and developmental biology·2026
Same author

AFG2A-related encephalopathy, expanding the neurodevelopmental and epileptic spectrum.

Orphanet journal of rare diseases·2026
Same author

Evaluating the Accuracy of Declared Eating Schedules by Continuous Glucose Monitoring.

Nutrients·2026
Same author

Consensus document on the treatment of insomnia in patients with autism spectrum disorder under 18 years of age.

Anales de pediatria·2026
Same author

Circadian alterations in isolated Rapid-Eye-Movement sleep behavior disorder: associations with clinical, glymphatic, and dopaminergic imaging markers.

Sleep·2026
Same author

Cannabidiol as Adjunctive Treatment in Drug-Resistant Epilepsy With Epileptic Spasms Beyond Two Years of Age.

Pediatric neurology·2025

Related Experiment Video

Updated: Mar 17, 2026

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

3.3K

[Insomnia in children and adolescents. A consensus document].

Gonzalo Pin Arboledas1, Víctor Soto Insuga2, María José Jurado Luque3

  • 1Asociación Española de Pediatría (AEP).

Anales De Pediatria (Barcelona, Spain : 2003)
|August 1, 2016
PubMed
Summary

Childhood insomnia affects learning and family well-being, impacting 30% of young children. This consensus highlights clinical diagnosis and cognitive-behavioral therapy as primary treatments for pediatric sleep issues.

Keywords:
AntihistaminicAntihistamínicoCognitive-behaviouralCognitivo-conductualInsomniaInsomnioMelatoninMelatonina

More Related Videos

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

1.7K
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.6K

Related Experiment Videos

Last Updated: Mar 17, 2026

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

3.3K
Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

1.7K
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.6K

Area of Science:

  • Pediatrics
  • Sleep Medicine
  • Child Psychology

Background:

  • Childhood insomnia is prevalent, affecting up to 30% of children under five.
  • Sleep disturbances in children lead to significant cognitive, emotional, and learning deficits.
  • Pediatrician training in diagnosing and managing childhood insomnia is often inadequate.

Framework:

  • A consensus document on managing childhood and adolescent insomnia.
  • Developed by leading Spanish pediatric and sleep medicine societies.
  • Emphasizes clinical diagnosis, reserving tests for complex cases.

Implementation:

  • Primary treatment focuses on cognitive-behavioral therapy (CBT).
  • Behavioral interventions include modifying sleep habits.
  • Discourages the use of medications without clear clinical guidelines.

Implications:

  • Improved diagnostic and treatment protocols for pediatric insomnia.
  • Enhanced quality of life for children and their families.
  • Addresses the gap in clinical guidelines for pharmacotherapy in pediatric sleep disorders.